(Q33970595)

30 July 2017

1 reference

title

Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies (English)

1 reference

30 July 2017

1 reference

Diel IJ

1

1 reference

30 July 2017

Solomayer EF

series ordinal

2

1 reference

30 July 2017

Bastert G

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

30 July 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

30 July 2017

88

1 reference

30 July 2017

3080-3088

1 reference

30 July 2017

12 Suppl

1 reference

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Molecular mechanisms of action of bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Effects of disodium etidronate in murine tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Palliative pamidronate treatment in patients with bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C3080%3A%3AAID-CNCR27%3E3.0.CO%3B2-W

10.1002/1097-0142(20000615)88:12+<3080::AID-CNCR27>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference